BUY Motilal Oswal Financial Services Limited — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))17 Aug 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Motilal Oswal Asset Management Company (MOAMC), a subsidiary, announced its Assets Under Management (AUM) crossed ₹2 lakh crore. This milestone covers Mutual Funds, PMS, and AIFs, highlighting the com
BSE · Company Update·10 Aug · 6d ago
Motilal Oswal sees private banks delivering 18-20% earnings growth in FY27
NewsCnbc-Tv18·5 Aug · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Motilal Oswal Financial Services
- BUY — Ansh Jogendra Bhilwar22 Oct 2026 · Same day · target ₹1,060 · Expired
- BUY — Rakesh Bansal16 Oct 2026 · Next day · target ₹1,095 · SL hit
- BUY — Ashish Chaturmohta, JM Financial15 Oct 2026 · ~1 year · target ₹1,200 · SL hit
- BUY — IDBI Capital15 Oct 2026 · ~2 weeks · target ₹1,122 · SL hit
- BUY — Amit Seth15 Oct 2026 · ~2 weeks · target ₹1,100 · SL hit
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

